Creegan & Nassoura Financial Group, LLC CVS — CVS HEALTH CORP

Ownership history in Creegan & Nassoura Financial Group, LLC  ·  29 quarters on record

AI Ownership Summary

Creegan & Nassoura Financial Group, LLC reported CVS HEALTH CORP (CVS) in 29 quarterly 13F filings from 2024 Q1 through 2025 Q3. Peak portfolio weight reached 1.94% in 2024 Q1. The latest visible filing shows CVS at 1.18% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CVS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Creegan & Nassoura Financial Group, LLC's position in CVS HEALTH CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

CVS was reported at 1.18% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.94% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CVS stock page Creegan & Nassoura Financial Group, LLC fund profile Creegan & Nassoura Financial Group, LLC full holdings
How Creegan & Nassoura Financial Group, LLC held CVS — position size vs. price
% of Fund (quarterly)    CVS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 REDUCED — — — 24,302 -890 -3.5% 1.18% $1.8M 2025-11-14 $76.50
2025 Q2 REDUCED 17.1% +10.7% ❌ 25,192 -5,185 -17.1% 1.13% $1.7M 2025-08-14 $65.08
2025 Q1 UNCHANGED — — — 30,377 — 0% 1.37% $2.1M 2025-05-15 $58.34
2024 Q4 REDUCED 14.8% +52.8% ❌ 30,377 -5,264 -14.8% 0.92% $1.4M 2025-02-14 $62.86
2024 Q3 REDUCED — — — 35,641 -790 -2.2% 1.41% $2.2M 2024-11-14 $51.94
2024 Q2 UNCHANGED — — — 36,431 — 0% 1.48% $2.2M 2024-08-14 $52.21
2024 Q1 UNCHANGED — — — 36,431 — 0% 1.94% $2.9M 2024-05-15 $51.88
22 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CVS

As of 2026 Q2 — sorted by position size

THOR INVESTMENT MANAGEMENT INC /OH/ /ADV 2.24% CACTI ASSET MANAGEMENT LLC 3Y 7Y 2.0% CX Institutional 3Y 7Y 0.3% First County Bank /CT/ 3Y 0.12% First Nebraska Trust Co 0.11% Versant Capital Management, Inc 3Y 7Y 0.09% Roxbury Financial LLC 0.04% Hilltop National Bank 0.03% EASTERN BANK 3Y 7Y 0.02% KERR FINANCIAL PLANNING Corp 0.01%

FAQ About Creegan & Nassoura Financial Group, LLC and CVS

These are the practical questions this page is built to answer before you even open the full history table.

How long has Creegan & Nassoura Financial Group, LLC reported owning CVS?

Creegan & Nassoura Financial Group, LLC reported CVS across 7 quarterly 13F filings, from 2024 Q1 through 2025 Q3.

What was the largest reported CVS position in Creegan & Nassoura Financial Group, LLC's portfolio?

The largest reported portfolio weight for CVS was 1.94% in 2024 Q1.

What is the latest reported CVS position on this page?

The most recent filing on this page is 2025 Q3, when Creegan & Nassoura Financial Group, LLC reported 24,302 shares, equal to 1.18% of portfolio, with an estimated market value of $1.8M.

What does the chart on this CVS ownership page compare?

The chart compares Creegan & Nassoura Financial Group, LLC's quarterly CVS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Creegan & Nassoura Financial Group, LLC time their CVS position?

Based on 13F filing dates vs. subsequent CVS price moves, Creegan & Nassoura Financial Group, LLC correctly timed 4 out of 16 reported position changes (25%). The annualised alpha on CVS relative to SPY over the holding period was -6.6%.

← Back to Creegan & Nassoura Financial Group, LLC Holdings